ABOUT

QURCAN THERAPEUTICS INC

QurCan Therapeutics fosters scientific creativity with pioneering nanotechnologies to accelerate first-in-class nanomedicines and improve patients’ quality of life.

QurCan Therapeutics is focused on the discovery and development of breakthrough therapeutics enabled by its proprietary nanotechnology drug delivery platform called “TERP”. We are committed to restoring health and transforming the lives of patients through the development of nanomedicine that requires the unique features of the TERP technology to address major unmet needs for the treatment of cancer and other major diseases.

OVERCOMING RESISTANCE TO CANCER THERAPY

Tumor hypoxia (lack of oxygen) is a common cause of resistance to cancer therapy. Under hypoxic conditions, cancer cells become more invasive, aggressive, and proliferative, leading to treatment resistance and failure.

DRUG DELIVERY PRECISELY WHERE IT'S NEEDED

Next-generation platform technology enables controlled delivery of therapeutic agents actively transported into cells and across the blood-brain barrier.